Medical Laboratory Scientist
Nancy Somi
 Viral load is the concentration of virus in the
blood stream.
 Its used in conjunction with other tests to
monitor the progress of patients.
 Its used as a primary indicator of therapeutic
efficacy.
 Used to monitor a change in ARV drugs in
drug resistance cases
 It’s a baseline indicator of disease
progression.
Due to advanced technology viral load assays are dramatically
changing to fit the current setting of developed and developing
countries. These assays differ in.
 Sensitivity
 Dynamic range
 Target region
 Extraction, amplification and detection in nucleic acid based
assays.
 Nucleic Acid Testing Technologies (NAT)-They
detect and quantify Viral RNA
 Non-Nucleic Testing Technologies( NNAT)
They are based on the detection and
quantification of HIV viral enzymes and proteins
which can be used as a correlate measure of viral
RNA.
Three major methods for detecting and quantifying
nucleic acids.
 Reverse transcription polymerase chain
reaction.(RT-PCR)
 Nucleic Acid Sequence Based
Amplification(NASBA)
 Branched chain DNA (bDNA)
 RT‐PCR is a method of PCR using a Reverse
Transcriptase (RT) enzyme to convert viral RNA
into complementary DNA (cDNA).
The cDNA undergoes replication and detection
. RT‐PCR is used to quantify HIV RNA and to
dertemine viral load.
 Amplicor HIV-1 monitor v1.5(Roche)
 Cobas Taqman (Roche)
 Real time HIV -1 (Abbot)
 VERSANT HIV-1 RNA ASSAY (kPCR)
 The COBAS Taqman is a real time PCR that
targets both the gag and LTR regions of the
HIV genome.
 Coupled with the COBAS Ampliprep, viral load
quantification is a fully automated process.
 It can detect as low as 20cp/ml.
 Can only be accessed by developed countries
and a very few places in developing countries.
 In developed countries it’s the most baseline
investigation in HIV positive patients.
“Science grows like a weed every year”.
Kary Mullis
THANK YOU!!!!!

Viral load test

  • 1.
  • 2.
     Viral loadis the concentration of virus in the blood stream.  Its used in conjunction with other tests to monitor the progress of patients.
  • 3.
     Its usedas a primary indicator of therapeutic efficacy.  Used to monitor a change in ARV drugs in drug resistance cases  It’s a baseline indicator of disease progression.
  • 4.
    Due to advancedtechnology viral load assays are dramatically changing to fit the current setting of developed and developing countries. These assays differ in.  Sensitivity  Dynamic range  Target region  Extraction, amplification and detection in nucleic acid based assays.
  • 5.
     Nucleic AcidTesting Technologies (NAT)-They detect and quantify Viral RNA  Non-Nucleic Testing Technologies( NNAT) They are based on the detection and quantification of HIV viral enzymes and proteins which can be used as a correlate measure of viral RNA.
  • 6.
    Three major methodsfor detecting and quantifying nucleic acids.  Reverse transcription polymerase chain reaction.(RT-PCR)  Nucleic Acid Sequence Based Amplification(NASBA)  Branched chain DNA (bDNA)
  • 7.
     RT‐PCR isa method of PCR using a Reverse Transcriptase (RT) enzyme to convert viral RNA into complementary DNA (cDNA). The cDNA undergoes replication and detection . RT‐PCR is used to quantify HIV RNA and to dertemine viral load.
  • 8.
     Amplicor HIV-1monitor v1.5(Roche)  Cobas Taqman (Roche)  Real time HIV -1 (Abbot)  VERSANT HIV-1 RNA ASSAY (kPCR)
  • 9.
     The COBASTaqman is a real time PCR that targets both the gag and LTR regions of the HIV genome.  Coupled with the COBAS Ampliprep, viral load quantification is a fully automated process.  It can detect as low as 20cp/ml.
  • 10.
     Can onlybe accessed by developed countries and a very few places in developing countries.  In developed countries it’s the most baseline investigation in HIV positive patients.
  • 11.
    “Science grows likea weed every year”. Kary Mullis THANK YOU!!!!!